Successful management of pregnancy in a patient with Eisenmenger syndrome with epoprostenol

Chest

Volumn 124, Issue 3, 2003, Pages 1170-1173

  Geohas, Chris ^a   McLaughlin, Vallerie V ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Eisenmenger syndrome; Epoprostenol; Pregnancy; Pulmonary hypertension

Indexed keywords

PROSTACYCLIN;

ADULT; APGAR SCORE; ARTICLE; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; DISEASE CLASSIFICATION; DRUG EFFICACY; DYSPNEA; EISENMENGER COMPLEX; FEMALE; FETUS DISTRESS; HEART ATRIUM SEPTUM DEFECT; HUMAN; NEWBORN; PREGNANCY; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 0141688386     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.3.1170     Document Type: Article

References (4)

1. Weiss BM, Zemp L, Seifert B, et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998; 31:1650-1657
2. Barst R, Rubin L, Long W, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334:296-301
3. Rosenzweig E, Kerstein D, Barst R. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999; 99:1858-1865
4. Brickner ME, Hillis LD, Lange RA. Congenital heart disease in adults. N Engl J Med 2000; 342:334-342